Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uveal Melanoma × Tamoxifen × Clear all

Sponsor

Conditions

Breast Neoplasms 58 Carcinoma, Intraductal, Noninfiltrating 6 Breast Neoplasms, Male 5 Neoplasms 3 Neoplasm Metastasis 3 Breast Carcinoma In Situ 3 Urinary Bladder Neoplasms 2 Inflammatory Breast Neoplasms 2 Sleep Wake Disorders 1 Risk Reduction Behavior 1 Obesity 1 Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer 1 Mastodynia 1 Glioma 1 Fibrocystic Breast Disease 1 Fibroadenoma 1 Fatigue 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Disease Progression 1 Desmoid Tumors 1 Cystic Fibrosis 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Lobular 1 Bulbo-Spinal Atrophy, X-Linked 1 Breast Cancer Metastatic 1 Brain Neoplasms 1 Arthralgia 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1

Interventions

Ipilimumab 5 pembrolizumab 4 Nivolumab 4 Dacarbazine 4 CTLA-4 Antigen 3 aflibercept 2 Temozolomide 2 Ranibizumab 2 Radiosurgery 2 Paclitaxel 2 Lenalidomide 2 Cyclophosphamide 2 Carboplatin 2 Bevacizumab 2 Albumin-Bound Paclitaxel 2 130-nm albumin-bound paclitaxel 2 utomilumab 1 ulixertinib 1 trametinib 1 tebentafusp 1 sotrastaurin 1 sargramostim 1 relatlimab 1 poly ICLC 1 pasireotide 1 omipalisib 1 oblimersen 1 niraparib 1 lenvatinib 1 glembatumumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡